These results lead to the conclusion that Fra-2 overexpression is not a frequent event in benign adenomas, raising the possibility that Fra-2 might contribute mainly to tumor progression during colorectal tumorigenesis [77] (Fig. 4). The gene discussed is FOSL2; the disease is neoplasm.